Viela Bio
is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases... Read moreViela Bio
is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases... Read more
News
Dec 12, 2023
Law 360
Viela Bio: AstraZeneca Urges Chancery To Toss $3B Viela Bio Sale Suit
Mar 16, 2021
CompanyNews HQ
Viela Bio: Divestment of Viela shareholding completed
Mar 16, 2021
The Business Journals: Baltimore
Viela Bio: Viela Bio closes its $3.05B sale. Here's what's next for its leadership team.
Mar 15, 2021
The Business Journals: Washington, D.C.
Viela Bio: Viela Bio closes $3.1B sale to European pharmaceutical company
Mar 01, 2021
GlobeNewswire
Press Release: Viela Bio : Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
Feb 25, 2021
GlobeNewswire
Press Release: Viela Bio : Viela Bio Announces Additional Positive Results with UPLIZNA (inebilizumab-cdon) in Patients with Neuromyelitis Optica Spectrum Disorder at the ACTRIMS 2021 Forum
Feb 22, 2021
BioSpace
Viela Bio: Viela Bio to Report Fourth Quarter and Full Year 2020 Operating and Financial Results on March 1, 2021
Feb 21, 2021
MarketScreener
Viela Bio: Viela Bio : (VIE Alert) Johnson Fistel Investigates Proposed Sale of Viela Bio; Are Shareholders Getting a Fair Deal?
Feb 13, 2021
Markets Insider
Viela Bio: SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Viela Bio, Inc. - VIE
Feb 10, 2021
Global Legal Chronicle
Viela Bio: Horizon Therapeutics' $3.05 Billion Acquisition Of Viela Bio
Viela Bio Competitors
1
2
3
4
5
6
7
8
9
10